{"id":"https://openalex.org/W2153555355","doi":"https://doi.org/10.1016/s0022-3565(24)37075-2","title":"P-Glycoprotein Mediates the Efflux of Quinidine across the Blood-Brain Barrier","display_name":"P-Glycoprotein Mediates the Efflux of Quinidine across the Blood-Brain Barrier","alternate_titles":[],"publication_year":1997,"publication_date":"1997-11-01","ids":{"openalex":"https://openalex.org/W2153555355","doi":"https://doi.org/10.1016/s0022-3565(24)37075-2","mag":"2153555355","pmid":"https://pubmed.ncbi.nlm.nih.gov/9353372"},"language":"en","primary_location":{"id":"doi:10.1016/s0022-3565(24)37075-2","doi":"https://doi.org/10.1016/s0022-3565(24)37075-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)37075-2","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2153555355"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061014418","display_name":"Hiroyuki Kusuhara","orcid":"https://orcid.org/0000-0002-3641-8746","observed_orcids":["https://orcid.org/0000-0002-3641-8746"]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroyuki Kusuhara","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)","Faculty of Pharmaceutical Sciences, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)","institution_ids":["https://openalex.org/I201537933","https://openalex.org/I74801974"]},{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111441742","display_name":"Hiroshi Suzuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Suzuki","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)","institution_ids":["https://openalex.org/I201537933","https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026158271","display_name":"Tetsuya Terasaki","orcid":"https://orcid.org/0000-0002-6332-7575","observed_orcids":["https://orcid.org/0000-0002-6332-7575"]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tetsuya Terasaki","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)","institution_ids":["https://openalex.org/I201537933","https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003500226","display_name":"Atsuyuki Kakee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Atsuyuki Kakee","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)","institution_ids":["https://openalex.org/I201537933","https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018370030","display_name":"Michel Lemaire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michel Lemaire","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)","institution_ids":["https://openalex.org/I201537933","https://openalex.org/I74801974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110046455","display_name":"Yuichi Sugiyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]},{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yuichi Sugiyama","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, The University of Tokyo, 7\u20133-1, Hongo, Bunkyo-ku, Tokyo, 113, Japan (H.K., H.S., A.K., Y.S.), Faculty of Pharmaceutical Sciences, Tohoku University, Aramaki aza-aoba, Aoba-ku, Sendai 980\u201377 Miyagi, Japan (T.T.), and Department of Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Basel, Switzerland (M.L.)","institution_ids":["https://openalex.org/I201537933","https://openalex.org/I74801974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5110046455"],"corresponding_institution_ids":["https://openalex.org/I201537933","https://openalex.org/I74801974"],"apc_list":{"value":3750,"currency":"USD","value_usd":3750},"apc_paid":null,"fwci":3.6596,"has_fulltext":false,"cited_by_count":167,"citation_normalized_percentile":{"value":0.93710894,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"283","issue":"2","first_page":"574","last_page":"580"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9990000128746033},{"id":"https://openalex.org/keywords/quinidine","display_name":"quinidine","score":0.9330000281333923},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.996999979019165},{"id":"https://openalex.org/keywords/efflux-transport","display_name":"efflux transport","score":0.7670000195503235},{"id":"https://openalex.org/keywords/brain-uptake","display_name":"brain uptake","score":0.6299999952316284},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.6669999957084656},{"id":"https://openalex.org/keywords/psc-833","display_name":"PSC833","score":0.8840000033378601},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.8550000190734863},{"id":"https://openalex.org/keywords/mdr1a-knockout-mice","display_name":"mdr1a knockout mice","score":0.9079999923706055},{"id":"https://openalex.org/keywords/drug-transporters","display_name":"drug transporters","score":0.3479999899864197}],"concepts":[{"id":"https://openalex.org/C2780339425","wikidata":"https://www.wikidata.org/wiki/Q412496","display_name":"Quinidine","level":2,"score":0.9684856534004211},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.8245818614959717},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.7927855849266052},{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.680006206035614},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6382931470870972},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5353463292121887},{"id":"https://openalex.org/C2777022698","wikidata":"https://www.wikidata.org/wiki/Q410291","display_name":"Verapamil","level":3,"score":0.4603211283683777},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36327114701271057},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3340049684047699},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.24444910883903503},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2213786244392395},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16931062936782837},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.10520479083061218},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.0},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003524","descriptor_name":"Cyclosporins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011802","descriptor_name":"Quinidine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0022-3565(24)37075-2","doi":"https://doi.org/10.1016/s0022-3565(24)37075-2","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0022-3565(24)37075-2","pdf_url":null,"source":{"id":"https://openalex.org/S102125482","display_name":"Journal of Pharmacology and Experimental Therapeutics","issn_l":"0022-3565","issn":["0022-3565","1521-0103"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1"],"host_organization":"https://openalex.org/P4310316283","host_organization_name":"American Society for Pharmacology and Experimental Therapeutics","host_organization_lineage":["https://openalex.org/P4310316283"],"host_organization_lineage_names":["American Society for Pharmacology and Experimental Therapeutics"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pharmacology and Experimental Therapeutics","raw_type":"journal-article"},{"id":"pmid:9353372","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9353372","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pharmacology and experimental therapeutics","raw_type":"Journal Article"},{"id":"mag:2153555355","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9353372","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W100270587","https://openalex.org/W205479812","https://openalex.org/W1594196316","https://openalex.org/W1624721816","https://openalex.org/W1737567770","https://openalex.org/W1881846348","https://openalex.org/W1925223276","https://openalex.org/W1979409628","https://openalex.org/W1983639543","https://openalex.org/W1992390087","https://openalex.org/W2013280216","https://openalex.org/W2017731672","https://openalex.org/W2030640565","https://openalex.org/W2035680395","https://openalex.org/W2040683695","https://openalex.org/W2051002936","https://openalex.org/W2067746647","https://openalex.org/W2070823797","https://openalex.org/W2078004577","https://openalex.org/W2079763637","https://openalex.org/W2081538957","https://openalex.org/W2087526401","https://openalex.org/W2090841445","https://openalex.org/W2092078486","https://openalex.org/W2098153467","https://openalex.org/W2112001901","https://openalex.org/W2136564762","https://openalex.org/W2171344824","https://openalex.org/W2269512218"],"related_works":["https://openalex.org/W1992553889","https://openalex.org/W2052371389","https://openalex.org/W2068820518","https://openalex.org/W2284156619","https://openalex.org/W2144114379","https://openalex.org/W176733150","https://openalex.org/W1992908365","https://openalex.org/W2789341094","https://openalex.org/W1990299751","https://openalex.org/W2153831826"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2153555355","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
